Compounds / Cognitive / Selank

Selank

Selank (Tuftsin Analog: Thr-Lys-Pro-Arg-Pro-Gly-Pro)
CognitiveWell ResearchedFDA: Not approved (registered in Russia)

Overview

Registered drug in Russia. Clinical trials: anxiolytic and cognitive-enhancing effects without benzodiazepine-type sedation or dependence. GAD studied in clinical population.

Mechanism of Action

Tuftsin tetrapeptide with Pro-Gly-Pro extension for metabolic stability. Modulates GABA-A receptor. Anxiolytic without sedation. Stabilizes serotonin/dopamine. Anti-inflammatory via IL-6 modulation.

Pharmacokinetics

Half-life
3 min
Peak (Tmax)
20 min
Cleared
~15 min

Molecular Profile

Molecular weight
751.89 Da
CAS number
129954-34-3
Type
Tuftsin analog
Length
7 amino acids
Thr-Lys-Pro-Arg-Pro-Gly-Pro

Key Research Findings

Anxiolytic without sedation/dependence; cognitive enhancement; GABA modulation; registered Russian drug.

Published Research

Bull Exp Biol Med
Semenova TP et al. Selank effects on anxiety and cognition
View source
CNS Drug Reviews
Zozulya AA et al. Selank and Semax: anxiolytic and neuroprotective mechanisms
View source

Related Cognitive Compounds

SemaxNA Semax AmidateAdalankAdamaxDihexaCerebrolysin
Clinical Guidance

Research data is not a treatment plan. If you are considering Selank, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.
Running Selank? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator  ·  Full deep dive  ·  Peptide fundamentals